Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes
NCT07516847
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes (MDS)
Anemia
Interventions
DRUG:
Dapagliflozin (10mg Tab)
Sponsor
Seug yun Yoon, MD
Collaborators
[object Object]